Researchers have developed novel lymph-node-inspired hydrogels that significantly enhance the activation, gene expression, ...

Most cancer genome studies have focused on mutations in the tumor itself and how such gene variants allow a tumor to grow unchecked.

Researchers have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of tumor-infiltrating ...

The researchers have discovered a wealth of new interactions and have identified potential new targets for cancer therapy, as ...

Precious metals are not merely ornaments; they are also important components of pharmaceuticals, like the antitumor drug cisplatin. Recently, the search for alternatives with improved activity has ...

Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates—only 10% after five years. One of the factors contributing to its aggressiveness is its tumor ...

Results of study led by investigators at the Vall d'Hebron Institute of Oncology (VHIO) show convergent genetic adaptation ...

Gastrointestinal (GI) cancers, such as colorectal, gastric, and pancreatic cancers, are among the most prevalent and deadly worldwide. Despite advances in ...

PGV001, a personalized cancer vaccine, induced immune responses across various cancer types like breast and urothelial cancer ...

Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors - a smart fighter that destroys cancer cells for days without tiring.

Treatments such as the Mohs procedure and fluorouracil can be effective in the fight against the most common type of cancer ...

Most people who have cancer cells in their bones don't have primary bone cancer. They have cancer cells that have spread into the bone from a cancer elsewhere in the body. This is called secondary or ...